Placo (603566) 2023 Report & 2024 Quarterly Report Review: Pig Seedling, Chemical and Other Businesses Under Pressure Await Cycle Recovery and Operating Inflection Point
Placo (603566): The pig breeding business is under pressure in the short term, the pig cycle reverses, and the future is bright
China Post Securities released a research report on April 28 stating that Placo (603566.SH) was rated to increase its holdings. The main reasons for the rating include: 1) Comments: Pig seedlings are a drag and management efficiency is improved; 2) Produc
Placo (603566): The swine vaccine boom is under pressure and concerns about procyclical performance to release flexibility
China Galaxy released a research report on April 25 stating that Placo (603566.SH) was given a recommended rating. The main reasons for the rating include: 1) the company's revenue & profit increased in 23, putting pressure on 24Q1 performance; 2) revenue
Placo (603566): Short-term results are under pressure, awaiting industry recovery and new product development
Placo (603566) Company Information Update Report: Performance is expected to reverse and repair with the pig cycle, high dividends highlight investment value
Placo (603566): 24Q1 performance is slightly under pressure, and the pet sector is expected to develop collaboratively
Placo (603566) review report: Exploring the blue ocean market for pet health through triple emergency assessment for cats
Placo (603566): 23Q3 profitability repairs, and the penetration rate of major customers continues to increase
Placo (603566): Focus on “big customers+big single products” strategic cost control and continuous optimization
Placo (603566): Cost optimization, performance, high growth, continued layout of the pet sector
Placo (603566) 2023 Third Quarter Report Review: Increased revenue and fees have shown results, and major projects are progressing steadily
Placo (603566) Company Information Update Report: Low pig prices and pig breeding growth are under pressure, and the pet sector is developing well
Placo (603566): Q3 swine vaccines and chemicals are under pressure on major customers+major single product strategies have achieved remarkable results
Placo (603566) 2023 three-quarter report review: cost reduction and efficiency continue to advance, pet medicine sector growth rate is impressive
Placo (603566): Revenue from pig seedlings declined slightly year-on-year in Q3, and performance was in line with expectations
Placo (603566): Cost reduction, efficiency management optimization, Q3 pig breeding revenue declined slightly year-on-year
Placo (603566): Reducing fees and increasing efficiency, and chemical drugs to increase pig seedlings are under slight pressure
Placo (603566): Innovation-driven, strong R&D capabilities, multiple breakthroughs, products can be expected in the future
No Data